[A Case of Nivolumab Responding to Multiple Lymph Node Metastases during Multidisciplinary Treatment for Esophageal Cancer].
Gan To Kagaku Ryoho
; 49(13): 1995-1997, 2022 Dec.
Article
en Ja
| MEDLINE
| ID: mdl-36733069
In nivolumab therapy for unresectable advanced esophageal cancer, there are a few cases that show a complete response, and long-term survival can be expected in such cases. Here, we report a case in which nivolumab had a complete response to multiple lymph node metastases during multidisciplinary treatment for esophageal cancer and survived for a relatively long period despite being elderly. Examination of complete response cases provides us with significant insights in considering the unexplained biomarkers of immune checkpoint inhibitors and treatment discontinuation during complete response.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Esofágicas
/
Nivolumab
Límite:
Aged
/
Humans
Idioma:
Ja
Revista:
Gan To Kagaku Ryoho
Año:
2022
Tipo del documento:
Article
Pais de publicación:
Japón